C5091001 C8 G2

C5091001 EN

Card Summary Component

Who may participate

This study is seeking healthy male and female participants, meaning that the participants will not have the condition being studied.

In addition to the criteria listed, participants must meet the following requirements:

  • Born in mainland China with 4 chinese grandparents
  • Have a minimum body weight of 45 kg
  • Have body Mass Index of 17.5 - 30.5 kg/m2
  • Be a non-smoker or a smoker with 5 cigarettes per day maximum
  • Be able to meet all study visit requirements

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.


18 - 65 years old



Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect?

Card Summary Component

What to expect

The study part 2 is planned to last for approximately 10 weeks. There are several examinations procedures required in connection with the study:

  • A screening examination during which you will sign a COVID ICD and the study ICD
  • 1 treatment period organised of 13 days and 12 nights in the PCRU.
  • A follow-up phone call, 28 to 35 days after the last administration of the study drug.



2 852€ + transport fees

Required overnight stay

12 nights


Healthy Chinese participants

Interested in participating?

New to clinical research? If you’re interested in becoming a participant or need more information on the registration process, please complete and submit the registration form. We will contact you as soon as possible.

Already in our database? If you’d like to subscribe for this study, please contact us by phone.

Studies (recruiters) For more information, call 0800/99.256 (from abroad: 0032/2. 556.70.02 or 00800/2636.2636 from France, The Netherlands, Germany, UK) or email us.

Personal data means any information relating to you as a natural person such as for example your name, your date of birth, your telephone number or information relating to your health or your medical condition.

The personal data you share with us when completing the registration form is collected by the Brussels PCRU in order to send you the relevant literature and the medical questionnaire. It will be processed in a strictly confidential manner and in conformity with all applicable legislations, especially the European and Belgian laws applicable to clinical trials, and the European and Belgian laws applicable to personal data protection.

Personal data protection is very important to our clinical research unit. That’s why we ask that you read our Privacy Notice available at https://privacycenter.pfizer.com/en/belgium.

All fields marked with * are required.